Yong Zhao - China CYTS Assistant Mang
| 600138 Stock | 9.78 0.30 2.98% |
Executive
Yong Zhao is Assistant Mang of China CYTS Tours
| Age | 52 |
| Address | CYTS Building, Beijing, China, 100007 |
| Phone | 86 10 5815 8717 |
| Web | https://www.cyts.com |
China CYTS Management Efficiency
The company has return on total asset (ROA) of 0.0185 % which means that it generated a profit of $0.0185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0278 %, meaning that it generated $0.0278 on every $100 dollars invested by stockholders. China CYTS's management efficiency ratios could be used to measure how well China CYTS manages its routine affairs as well as how well it operates its assets and liabilities. At present, China CYTS's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 1.3 B, whereas Other Current Assets are forecasted to decline to about 121.6 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Hai Wang | Harbin Hatou Investment | 45 | |
| Zhaofeng Meng | Changchun BCHT Biotechnology | 61 | |
| Wentian Li | Shenzhen Bioeasy Biotechnology | 33 | |
| Anping Liu | Sichuan Hebang Biotechnology | 59 | |
| Chengli Zhang | Shanghai Rightongene Biotechnol | 67 | |
| Chengxiu Han | Anhui Huaheng Biotechnology | 35 | |
| Changlin Zhu | Changchun BCHT Biotechnology | 56 | |
| Dawei Liu | Changchun BCHT Biotechnology | 53 | |
| Junyan He | Shanghai Rightongene Biotechnol | 52 | |
| Zhicheng Liu | Anhui Huaheng Biotechnology | 40 | |
| Liqun Xie | Shanghai Rightongene Biotechnol | 61 | |
| Qi Pan | Harbin Hatou Investment | 61 | |
| Zhe Zhang | Changchun BCHT Biotechnology | 49 | |
| Changyong Fan | Jiangsu GDK Biotechnology | 43 | |
| Xiaohui Chen | Changchun BCHT Biotechnology | N/A | |
| Shu Jia | Harbin Hatou Investment | 62 | |
| Wei Wei | Changchun BCHT Biotechnology | 55 | |
| Siqing Tang | Anhui Huaheng Biotechnology | 43 | |
| Yaqin Chi | Shenzhen Bioeasy Biotechnology | 40 | |
| Huirong Yang | Sichuan Hebang Biotechnology | 58 | |
| Siying Jiang | Sichuan Hebang Biotechnology | 38 | |
Management Performance
| Return On Equity | 0.0278 | ||||
| Return On Asset | 0.0185 |
China CYTS Tours Leadership Team
Elected by the shareholders, the China CYTS's board of directors comprises two types of representatives: China CYTS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China CYTS's management team and ensure that shareholders' interests are well served. China CYTS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China CYTS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fan CPA, Secretary VP | ||
| Zheng Jiao, VP | ||
| Xi Xu, VP Director | ||
| Jun Lin, VP | ||
| Yong Zhao, Assistant Mang | ||
| Fan Yuan, Secretary VP | ||
| Wen Qiu, Vice Pres | ||
| Hao Chai, Assistant Pres |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China CYTS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0278 | ||||
| Return On Asset | 0.0185 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 12.26 B | ||||
| Shares Outstanding | 723.84 M | ||||
| Shares Owned By Insiders | 24.47 % | ||||
| Shares Owned By Institutions | 4.27 % | ||||
| Price To Book | 1.16 X | ||||
| Price To Sales | 0.74 X |
Currently Active Assets on Macroaxis
Other Information on Investing in China Stock
China CYTS financial ratios help investors to determine whether China Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China CYTS security.